Align Technology Inc

ALGN trades at a P/E of 31.2 despite sitting 47.4 on the RSI—neither overbought nor oversold—suggesting the market hasn't fully priced in either recovery optimism or deterioration risk. The 6.08% short interest is moderate, indicating some skepticism but no imminent squeeze catalyst. At $12.4B in market cap, ALGN occupies the mid-cap space where institutional positioning can matter significantly. The stock's valuation sits above historical norms for a mature orthodontics leader, implying growth expectations are already baked in; any miss on execution could see multiple compression, while upside requires the company to justify that premium through accelerating revenue or margin expansion.